Expert Consensus on Pediatric Urodynamics Reporting Using Modified Delphi Technique.


Journal

The Journal of urology
ISSN: 1527-3792
Titre abrégé: J Urol
Pays: United States
ID NLM: 0376374

Informations de publication

Date de publication:
Jul 2024
Historique:
medline: 11 6 2024
pubmed: 3 5 2024
entrez: 3 5 2024
Statut: ppublish

Résumé

Urodynamic testing (UDS) is an important tool in the management of pediatric lower urinary tract conditions. There have been notable efforts to standardize pediatric UDS nomenclature and technique, but no formal guidelines exist on essential elements to include in a clinical report. We sought to identify ideal structure and elements of a pediatric UDS assessment based on expert consensus. Pediatric urologists regularly performing UDS were queried using a Delphi process. Participants were invited representing varied geographic, experience, and societal involvement. Participants underwent 3 rounds of questionnaires between November 2022 and August 2023 focusing on report organization, elements, definitions, and automated electronic health record clinical decision support. Professional billing requirements were also considered. Consensus was defined as 80% agreeing either in favor of or against a topic. Elements without consensus were discussed in subsequent rounds. A diverse sample of 30 providers, representing 27 institutions across 21 US states; Washington, District of Columbia; and Canada completed the study. Participants reported interpreting an average number of 5 UDS reports per week (range 1-22). The finalized consensus report identifies 93 elements that should be included in a pediatric UDS report based on applicable study conditions and findings. This consensus report details the key elements and structure agreed upon by an expert panel of pediatric urologists. Further standardization of documentation should aid collaboration and research for patients undergoing UDS. Based on this information, development of a standardized UDS report template using electronic health record implementation principles is underway, which will be openly available for pediatric urologists.

Identifiants

pubmed: 38700226
doi: 10.1097/JU.0000000000004000
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

165-174

Commentaires et corrections

Type : CommentIn

Auteurs

Kristen M Meier (KM)

Division of Urology, Children's Mercy Hospital, Children's Mercy Kansas City, Kansas City, Missouri.

Claudia Mata (C)

Children's Hospital of Colorado, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, Colorado.

Jill L Kaar (JL)

Children's Hospital of Colorado, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, Colorado.

Adam J Rensing (AJ)

Department of Urology, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma.

Anne G Dudley (AG)

Division of Urology, Connecticut Children's Hospital, Hartford, Connecticut.

Alonso Carrasco (A)

Pediatric Urology, Children's Minnesota, Minneapolis, Minnesota.

Beth A Drzewiecki (BA)

Division of Urology, Massachusetts General for Children, Boston, Massachusetts.

Brian A VanderBrink (BA)

Division of Urology, Cincinnati Children's Hospital, Cincinnati, Ohio.

Courtney S Streur (CS)

Department of Urology, University of Michigan, Ann Arbor, Michigan.

Darius J Bagli (DJ)

Division of Urology, The Hospital for Sick Children and Research Institute, Toronto, Ontario, Canada.

David J Chalmers (DJ)

Division of Urology, Maine Medical Center, Portland, Maine.

Duncan T Wilcox (DT)

Department of Pediatric Urology, Children's Hospital Colorado, Aurora, Colorado.

Elizabeth B Yerkes (EB)

Division of Urology, Lurie Children's Hospital, Chicago, Illinois.

Glen A Lau (GA)

Division of Urology, University of Utah Health, Salt Lake City, Utah.

Gino J Vricella (GJ)

Division of Urology, Children's Mercy Hospital, Kansas City, Missouri.

Sarah L Hecht (SL)

Department of Pediatric Urology, Oregon Health & Science University Doernbecher Children's Hospital, Portland, Oregon.

Hillary L Copp (HL)

Department of Urology, University of California, San Francisco Benioff Children's Hospitals, San Francisco, California.

Hans G Pohl (HG)

Division of Urology, Children's National Hospital, Washington, District of Columbia.

Israel Franco (I)

Section of Pediatric Urology, Yale School of Medicine, New Haven, Connecticut.

Jennifer Ahn (J)

Division of Urology, Seattle Children's Hospital, Seattle, Washington.

John S Wiener (JS)

Section of Pediatric Urology, Duke University Medical Center, Durham, North Carolina.

Jennifer S Singer (JS)

Department of Urology, University of California, Los Angeles Health, Los Angeles, California.

Christopher J Long (CJ)

Division of Pediatric Urology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Melise A Keays (MA)

Department of Urology, Boston Children's Hospital, Boston, Massachusetts.

Michael R Daugherty (MR)

Division of Urology, Cincinnati Children's Hospital, Cincinnati, Ohio.

Molly E Fuchs (ME)

Department of Urology, Nationwide Children's Hospital, Columbus, Ohio.

Paul F Austin (PF)

Division of Urology, Texas Children's Hospital, Houston, Texas.

Charlotte Q Wu (CQ)

Division of Pediatric Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Rebecca S Zee (RS)

Department of Urology, Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, Virginia.

Rosalia Misseri (R)

Department of Pediatric Urology, Riley Hospital for Children at Indiana University Health, Indianapolis, Indiana.

Stacy T Tanaka (ST)

Department of Urology, Children's Hospital of Alabama, Birmingham, Alabama.

Stuart B Bauer (SB)

Department of Urology, Boston Children's Hospital, Boston, Massachusetts.

Kyle O Rove (KO)

Department of Pediatric Urology, Children's Hospital Colorado, Aurora, Colorado.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH